Certified by Founder Lodge
Novartis
Switzerland - Basel, Baselstadt
INVESTOR
1 Disclosed Funding Rounds $223,000,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treat
| Company | Date | Round | Raised |
|---|---|---|---|
 Cleerly |
July, 25 ,2022 | Series C | $223,000,000 |
 Flare Therapeutics |
March, 23 ,2023 | Series B | $123,000,000 |
 RxLightning Inc. |
June, 07 ,2023 | Series A | $17,500,000 |
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
